Skip to main content

Acute Intracranial Hemorrhage clinical trials at University of California Health

1 research study open to eligible people

Showing trials for
  • Trial of Andexanet Alfa in ICH Patients Receiving an Oral FXa Inhibitor

    open to eligible people ages 18 years and up

    Randomized, controlled clinical trial evaluating the efficacy and safety of andexanet alfa versus usual care in patients with intracranial hemorrhage anticoagulated with a direct oral or indirect subcutaneous/intravenous anticoagulant

    at UC Irvine

Last updated: